Search

As COVID-19 spreads globally, populations who survive their illness will become immune. Mayo Vaccine




Populations who survive their illness will become immune. Mayo Vaccine Research Group Director Gregory Poland, MD, discusses antibody responses, duration of immunity, vaccine candidates and prospects for using convalescent serum to passively immunize unexposed high-risk people.



Source and credit Elsevier’s . www.elsevier.com

31 views0 comments
  • LinkedIn
  • Facebook

©2020 by IEEARC